Prime Medicine, Inc. - PRME
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 17, 2026 | SCHEDULE 13G/A | T. Rowe Price Investment Management, Inc. | 3.3% | 5,995,183 | View |
| Nov 14, 2025 | SCHEDULE 13G | T. Rowe Price Investment Management, Inc. | 5.3% | 9,236,955 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | GV 2019, L.P. | 7.5% | 10,100,058 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | GV 2019 GP, L.P. | 7.5% | 10,100,058 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | GV 2019 GP, L.L.C. | 7.5% | 10,100,058 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | GV 2021, L.P. | 2.4% | 3,262,440 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | GV 2021 GP, L.P. | 2.4% | 3,262,440 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | GV 2021 GP, L.L.C. | 2.4% | 3,262,440 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | GV 2023, L.P. | 2.4% | 3,200,000 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | GV 2023 GP, L.P. | 2.4% | 3,200,000 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | GV 2023 GP, L.L.C. | 2.4% | 3,200,000 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Alphabet Holdings LLC | 12.3% | 16,562,498 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | XXVI Holdings Inc. | 12.3% | 16,562,498 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Alphabet Inc. | 12.3% | 16,562,498 | View |
| Nov 05, 2025 | SCHEDULE 13G/A | FMR LLC | 3.8% | 6,731,796 | View |
| Nov 05, 2025 | SCHEDULE 13G/A | Abigail P. Johnson | 3.8% | 6,731,796 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.